Cardiovascular Risk Factors Among Patients Infected with COVID-19 in Saudi Arabia

References

• World Health Organisation. Weekly operational update on COVID-19- Emergency situational updates; 2020.
   Google Scholar
• Weqaya-Saudi Center for Disease Control and Prevention. COVID- 19 daily update of cases. Riyadh SA; 2020.
   Google Scholar
• Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese center for disease control and prevention. JAMA. 2020;323(13):1239–1242. doi:10.1001/jama.2020.2648
   PubMed Web of Science ®Google Scholar
• Garg S, Kim L, Whitaker M. Hospitalization rates and characteristics of patients hospitalized with laboratory-confirmed coronavirus disease 2019—COVID-NET, 14 States, March 1–30, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(15):458. doi:10.15585/mmwr.mm6915e3
   PubMed Web of Science ®Google Scholar
• Hariyanto TI, Kurniawan A. Dyslipidemia is associated with severe coronavirus disease 2019 (COVID-19) infection. Diabetes Metab Syndr. 2020;14(5):1463–1465. doi:10.1016/j.dsx.2020.07.054
   PubMed Web of Science ®Google Scholar
• Hariyanto TI, Kurniawan A. Metformin use is associated with reduced mortality rate from coronavirus disease 2019 (COVID-19) infection. Obes Med. 2020;19:100290. doi:10.1016/j.obmed.2020.100290
   Google Scholar
• Alsofayan YM, Althunayyan SM, Khan AA, Hakawi AM, Assiri AM. Clinical characteristics of COVID-19 in Saudi Arabia: a national retrospective study. J Infect Public Health. 2020;13(7):920–925. doi:10.1016/j.jiph.2020.05.026
   PubMed Web of Science ®Google Scholar
• Statistics GAo. Household Health Survey; 2018.
   Google Scholar
• Conroy RM, Pyörälä K, Fitzgerald A, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J. 2003;24(11):987–1003. doi:10.1016/S0195-668X(03)00114-3
   PubMed Web of Science ®Google Scholar
• D’agostino RB, Vasan RS, Pencina MJ, et al. General cardiovascular risk profile for use in primary care. Circulation. 2008;117(6):743–753. doi:10.1161/CIRCULATIONAHA.107.699579
   PubMed Web of Science ®Google Scholar
• AlQuaiz AM, Siddiqui AR, Kazi A, Batais MA, Al-Hazmi AM. Sedentary lifestyle and Framingham risk scores: a population-based study in Riyadh city, Saudi Arabia. BMC Cardiovasc Disord. 2019;19(1):88. doi:10.1186/s12872-019-1048-9
   PubMedGoogle Scholar
• Yang X, Yu Y, Xu J, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020;8(5):475–481. doi:10.1016/S2213-2600(20)30079-5
   PubMed Web of Science ®Google Scholar
• Algaissi AA, Alharbi NK, Hassanaine M, Hashem AM. Preparedness and response to COVID-19 in Saudi Arabia: building on MERS experience. J Infect Public Health. 2020;13(6):834–838. doi:10.1016/j.jiph.2020.04.016.
   PubMed Web of Science ®Google Scholar
• Badawi A, Ryoo SG. Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis. Int J Infect Dis. 2016;49:129–133. doi:10.1016/j.ijid.2016.06.015
   PubMed Web of Science ®Google Scholar
• Assiri A, Al-Tawfiq JA, Al-Rabeeah AA, et al. Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study. Lancet Infect Dis. 2013;13(9):752–761. doi:10.1016/S1473-3099(13)70204-4
   PubMed Web of Science ®Google Scholar
• Alsahafi AJ, Cheng AC. The epidemiology of Middle East respiratory syndrome coronavirus in the Kingdom of Saudi Arabia, 2012–2015. Int J Infect Dis. 2016;45:1–4. doi:10.1016/j.ijid.2016.02.004
   PubMed Web of Science ®Google Scholar
• McCormack V, Tolhurst-Cleaver S. Acute respiratory distress syndrome. BJA Educ. 2017;17(5):161–165. doi:10.1093/bjaed/mkx002
   Web of Science ®Google Scholar
• Force AD, Ranieri VM, Rubenfeld GD, et al. Acute respiratory distress syndrome: the Berlin definition. JAMA. 2012;307(23):2526–2533. doi:10.1001/jama.2012.5669
   PubMed Web of Science ®Google Scholar
• Mercado MG, Smith DK, Guard E. Acute kidney injury: diagnosis and management. Am Fam Physician. 2019;100(11):687–694.
   PubMed Web of Science ®Google Scholar
• Kurmani S, Squire I. Acute heart failure: definition, classification and epidemiology. Curr Heart Fail Rep. 2017;14(5):385–392. doi:10.1007/s11897-017-0351-y
   PubMedGoogle Scholar
• Mauvais-Jarvis F. Aging, male sex, obesity, and metabolic inflammation create the perfect storm for COVID-19. Diabetes. 2020;69(9):1857–1863. doi:10.2337/dbi19-0023
   PubMed Web of Science ®Google Scholar
• Palaiodimos L, Kokkinidis DG, Li W, et al. Severe obesity, increasing age and male sex are independently associated with worse in-hospital outcomes, and higher in-hospital mortality, in a cohort of patients with COVID-19 in the Bronx, New York. Metabolism. 2020;108:154262. doi:10.1016/j.metabol.2020.154262
   PubMed Web of Science ®Google Scholar
• Shah BR, Hux JE. Quantifying the risk of infectious diseases for people with diabetes. Diabetes Care. 2003;26(2):510–513. doi:10.2337/diacare.26.2.510
   PubMed Web of Science ®Google Scholar
• Erener S. Diabetes, infection risk and COVID-19. Mol Metab. 2020;39:101044. doi:10.1016/j.molmet.2020.101044
   PubMed Web of Science ®Google Scholar
• Hodgson K, Morris J, Bridson T, Govan B, Rush C, Ketheesan N. Immunological mechanisms contributing to the double burden of diabetes and intracellular bacterial infections. Immunology. 2015;144(2):171–185. doi:10.1111/imm.12394
   PubMed Web of Science ®Google Scholar
• Huang I, Lim MA, Pranata R. Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia–a systematic review, meta-analysis, and meta-regression. Diabetes Metab Syndr. 2020;14(4):395–403. doi:10.1016/j.dsx.2020.04.018
   PubMed Web of Science ®Google Scholar
• Yang J, Tian C, Chen Y, Zhu C, Chi H, Li J. Obesity aggravates COVID‐19: an updated systematic review and meta‐analysis. J Med Virol. 2020.
   Google Scholar
• Jin J-M, Bai P, He W, et al. Gender differences in patients with COVID-19: focus on severity and mortality. Front Public Health. 2020;8:152. doi:10.3389/fpubh.2020.00152
   PubMed Web of Science ®Google Scholar
• Li X, Xu S, Yu M, et al. Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan. J Allergy Clin Immunol. 2020;146(1):110–118. doi:10.1016/j.jaci.2020.04.006
   PubMed Web of Science ®Google Scholar
• Hariyanto TI, Valeriani K, Kwenandar F, et al. Inflammatory and hematologic markers as predictors of severe outcomes in COVID-19 infection: a systematic review and meta-analysis. Am J Emerg Med. 2020;41:110–119. doi:10.1016/j.ajem.2020.12.076
   PubMed Web of Science ®Google Scholar
• Koh J, Shah SU, Chua PEY, Gui H, Pang J. Epidemiological and clinical characteristics of cases during the early phase of COVID-19 pandemic: a systematic review and meta-analysis. Front Med. 2020;7:295. doi:10.3389/fmed.2020.00295
   Web of Science ®Google Scholar
• Momtazmanesh S, Shobeiri P, Hanaei S, Mahmoud-Elsayed H, Dalvi B, Rad EM. Cardiovascular disease in COVID-19: a systematic review and meta-analysis of 10,898 patients and proposal of a triage risk stratification tool. Egypt Heart J. 2020;72(1):1–17. doi:10.1186/s43044-020-00075-z
   Google Scholar
• Lloyd-Jones DM, Wilson PW, Larson MG, et al. Framingham risk score and prediction of lifetime risk for coronary heart disease. Am J Cardiol. 2004;94(1):20–24. doi:10.1016/j.amjcard.2004.03.023
   PubMed Web of Science ®Google Scholar
• Jahangiry L, Farhangi MA, Rezaei F. Framingham risk score for estimation of 10-years of cardiovascular diseases risk in patients with metabolic syndrome. J Health Popul Nutr. 2017;36(1):36. doi:10.1186/s41043-017-0114-0
   PubMedGoogle Scholar
• Barry M, Al Amri M, Memish ZA. COVID-19 in the shadows of MERS-CoV in the Kingdom of Saudi Arabia. J Epidemiol Glob Health. 2020;10(1):1–3. doi:10.2991/jegh.k.200218.003
   PubMed Web of Science ®Google Scholar
• Madjid M, Safavi-Naeini P, Solomon SD, Vardeny O. Potential effects of coronaviruses on the cardiovascular system: a review. JAMA Cardiol. 2020;5(7):831. doi:10.1001/jamacardio.2020.1286
   PubMed Web of Science ®Google Scholar
• Kwenandar F, Japar KV, Damay V, et al. Coronavirus disease 2019 and cardiovascular system: a narrative review. Int J Cardiol Heart Vasc. 2020;29:100557. doi:10.1016/j.ijcha.2020.100557
   PubMed Web of Science ®Google Scholar
• Hariyanto TI, Kurniawan A. Statin therapy did not improve the in-hospital outcome of coronavirus disease 2019 (COVID-19) infection. Diabetes Metab Syndr. 2020;14(6):1613–1615. doi:10.1016/j.dsx.2020.08.023
   PubMed Web of Science ®Google Scholar